Biotransformation of nanoplastics in human plasma and their permeation through a model in vitro blood-brain barrier: An in-depth quantitative analysis

DOI: 10.1016/j.nantod.2024.102466

Authors: Fazel Abdolahpur Monikh; Šárka Lehtonen; Jukka Kekäläinen; Isabel Karkossa; Seppo Auriola; Kristin Schubert; Alessandra Zanut; Sanni Peltonen; Jonna Niskanen; Mandar Bandekar; Martin von Bergen; Jari T.T. Leskinen; Arto Koistinen; Sara Bogialli; Zhiling Guo; Jussi V.K. Kukkonen; Chunying Chen; Iseult Lynch

Step 1: iPSC/ESC maintainance

day 0 ~ 1 (duration missing in database; assumed 1 day)

culture “unspecified method” human PSC in “unspecified medium”.

Step 2: endothelial 1

day 1 ~ 2 (duration missing in database; assumed 1 day)

culture “unspecified method” human PSC in “unspecified medium”.

Ideally, “EC” should express “ZO-1”, “PECAM1”, “CDH5”, “CLDN5”, “OCLN”, “TJP1”, “SLC2A1” at the end of culture.